SEOUL, July 3 (Korea Bizwire) – Lotte Biologics Co. said Wednesday it has begun construction of its first production facility in South Korea, aiming to become one of the top 10 companies in the global contract development and manufacturing organization (CDMO) market. The plant, with a manufacturing capacity of 120,000 tons, is being built in [...]
SEOUL, April 18 (Korea Bizwire) — Lotte Biologics Co., a pharmaceutical unit under the South Korean retail giant Lotte Group, said Tuesday it will invest US$48 million into its recently acquired U.S. plant to upgrade and boost its production capacity. The Korean company purchased the factory from global biopharmaceutical company Bristol Myers Squibb in Syracuse, [...]
SEOUL, Jan. 11 (Korea Bizwire) — Lotte Biologics Co., a pharmaceutical unit under the retail giant Lotte Group, said Wednesday it will invest US$3 billion to build a bio industrial complex in South Korea by 2030 that houses three plants. Its CEO, Lee Won-jik, announced the plan during the J.P. Morgan Healthcare Conference held in [...]